Login

Forward looking statements about Cyclacel Pharmaceuticals, Inc. - Spiro Rombotis, President and CEO of Cyclacel Pharmaceuticals, Inc. 00:00:00

Share On Facebook Share On Twitter

Cyclacel Pharmaceuticals is a clinical-stage biopharmaceutical company using its expertise in cell cycle, transcriptional regulation and DNA damage response biology in cancer cells to develop innovative medicines. The transcriptional regulation program is evaluating CYC065, a CDK inhibitor, in patients with advanced solid cancers and in combination with venetoclax in patients with advanced hematological malignancies.

Recent Videos

00:10:00
Thomas Olin Highlights Kancera’s Latest Advances and Strategic Focus | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Pablo Pereiro Discusses Squirrel Media’s 63% Profit Growth and 14.7% Stock Surge | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Steve Oliver of musicMagpie Discusses Circular Economy and Company's Growth Strategy | Steve Oliver , CEO , musicMagpie PLC.
00:10:00
Revolutionizing Healing with Naturally Derived Psychedelics | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
SMC Global Securities Launches New Office at Bahu Plaza, Jammu, to Promote Share Market Investments | Ajay Garg , CEO , SMC Global Securities Ltd.
00:10:00
Exploring Demoralization Syndrome Treatment with Filament Health’s Psilocybin Trials | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
BioInvent CEO Explores Portfolio Strategy and Upcoming Breakthroughs | Dr. Martin Welschof, CEO , BioInvent International AB.
00:10:00
Piotr Figarski Discusses Image Power's 2022 Results and Future Trends | Piotr Figarski, Vice President , Image Power SA.
00:10:00
Pablo Pereiro and María Bonaria Fois Discuss Squirrel Media's Strategic Acquisition of Mondo TV Studios | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Lexington Gold Set to List on London AIM Exchange After Reverse Takeover | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.
00:10:00
Thomas Olin, CEO of Kancera AB, Discusses Strategic Advances in Biopharma Innovation | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Leading the Charge in the Psychedelic Movement with Filament Health | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Pini Mandel on the Power of Dynamic Pricing to Boost Retail KPIs and Customer Satisfaction | Pini Mandel , CEO , Quicklizard Ltd.
00:10:00
Jean Michel Ng Tseung, New CEO of MCB Group, Shares Vision for a Sustainable Future | Jean Michel Ng Tseung , CEO , MCB Group Ltd.
00:10:00
Viktor Garmiani Unveils Candles Scandinavia’s Q4 Report Highlights | Viktor Garmiani, CEO , Candles Scandinavia AB.
00:10:00
Squirrel Media's Record-Breaking Year: CEO Pablo Pereiro Discusses Key Strategies and Global Expansion | Pablo Pereiro , CEO , Squirrel Media SA.

Suggestions

00:10:00
Senior Resources: Advancing Twin Hills Gold Project in Namibia with Prominent Shareholders
00:10:00
Barksdale Resources: Unveiling Promising Base Metal Exploration at One-to-One Mining Conference in New York
00:10:00
Barksdale Capital: Exploring Promising Base Metal Assets in Southern Arizona
00:10:00
TAURON Polska Energia SA's Financial Performance and Future Plans | Marek Wadowski, Vice-President ,Tauron Polska Energia SA.
00:10:00
Narciso Berberana, CEO of Aguas Andinas, leads strategic initiatives in water management and infrastructure development.
00:10:00
M. Fribourg interviewed by Jean-Marc Sylvestre | Michaël Fribourg, CEO, Chargeurs SACRI:PAR
00:10:00
O Cisco Metals: Advancing Gaspe Copper Project and Strategic Partnerships in Canada
00:10:00
Dimensional: Implementing Finance Science in Investment Management
00:10:00
Exploring the Vision and Performance of a European REIT | Simon Garing, CEO, Cromwell European Real Estate Investment Trust.
00:10:00
Tura Group CEO Stefan Eriksson Discusses Key Highlights in Q4 and 2023 Year-End Report | Stefan Eriksson ,CEO , TURA GROUP AB.
00:10:00
Estate Planning Essentials: Understanding the Clayton Election
00:10:00
looking for an alternative title that captures the essence of "Distinguished Innovator|Amit Kumar,Partner,Accel

© 2017 - Townhall + Tv